← Evidence map

ArticleJournal of neuroinflammation2022

Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway.

Ruozhi Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

254 papers cite itlatest 60 shown

2022
…
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35130906